Regulated hepatic insulin gene therapy of STZ-diabetic rats

Gene Therapy

Volumn 7, Issue 20, 2000, Pages 1744-1752

  Thule P M ^a   Liu, J M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Diabetes mellitus; Gene therapy; Insulin; Liver

Indexed keywords

GLUCOSE; INSULIN; STREPTOZOCIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; IN VIVO STUDY; INSULIN RELEASE; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL CULTURE TECHNIQUES; DIABETES MELLITUS, EXPERIMENTAL; GENE THERAPY; GENETIC VECTORS; HEPATOCYTES; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRANSGENES;

ADENOVIRIDAE; ANIMALIA; RODENTIA;

EID: 0033765795     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301297     Document Type: Article

References (32)

1. Type I diabetes mellitus: A chronic autoimmune disease
2. Regulation of insulin-gene expression
3. Gene therapy for diabetes mellitus in rats by hepatic expression of insulin
4. Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin
5. Transplantation of genetically engineered insulin-producing hepatocytes into immunoincompetent mice
6. Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations
7. Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats
8. Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice
9. Insulin production by engineered muscle cells
10. Glucose regulated production of human insulin in rat heptocytes
11. Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin
12. Diurnal variations in blood chemical items in Sprague-Dawley rats
13. Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum
14. Implantation of genetically engineered fibroblasts into mice: Implications for gene therapy
15. Introduction and expression of the human insulin gene in adult rat liver
16. Insulin gene transfer compensates pancreatic α-cell function in diabetic rats
17. Defective adeno-associated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice
18. Insulin delivery with plasmid DNA
19. Insulin replacement therapy for the rat model of streptozotocin-induced diabetes mellitus
20. Pulsatile intravenous insulin replacement in streptozotocin-diabetic rats is more efficient than continuous delivery: Effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis
21. Beta-cell proliferation in normal and streptozotocin-treated newborn rats: Site, dynamics and capacity
22. Persistent transgene expression in mouse liver following in vivo gene transfer with a DeltaE1/DeltaE4 adenovirus vector
23. Promoter attenuation in gene therapy: Interferongamma and tumor necrosis factor-alpha inhibit transgene expression
24. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX in mouse liver
25. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: Involvement of NF-κ-B
26. Regulatable production of insulin from primary-cultured hepatocytes: Insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin
27. Regulated production of mature insulin by non-β-cells
28. Specific problems facing gene therapy for insulin-dependent diabetes mellitus: Glucose-regulated insulin secretion from hepatocytes
29. Gene therapy of diabetes: Glucose-stimulated insulin secretion in a human hepatoma cell line (HEP G2ins/g)
30. Neutralization of virus
31. Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion
32. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy